SELLAS Life Sciences Group Inc [NASDAQ: SLS] slipped around -0.19 points on Wednesday, while shares priced at $1.9 at the close of the session, down -9.09%.
SELLAS Life Sciences Group Inc stock is now 57.02% up from its year-to-date (YTD) trading value. SLS Stock saw the intraday high of $2.12 and lowest of $1.88 per share. The company’s 52-week high price is 2.27, which means current price is +123.40% above from all time high which was touched on 07/02/25.
Compared to the average trading volume of 2.77M shares, SLS reached a trading volume of 3834923 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about SELLAS Life Sciences Group Inc [SLS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLS shares is $5.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for SELLAS Life Sciences Group Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 21, 2021. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on November 01, 2018, representing the official price target for SELLAS Life Sciences Group Inc stock. Previously, the target price had yet another raise to $11, while H.C. Wainwright analysts kept a Buy rating on SLS stock.
The Price to Book ratio for the last quarter was 6.22, with the Price to Cash per share for the same quarter was set at 0.29.
How has SLS stock performed recently?
SELLAS Life Sciences Group Inc [SLS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.65. With this latest performance, SLS shares gained by 18.01% in over the last four-week period, additionally plugging by 75.93% over the last 6 months – not to mention a rise of 82.69% in the past year of trading.
SELLAS Life Sciences Group Inc [SLS]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -91.36%, with Return on Assets sitting at -91.36%.
Earnings analysis for SELLAS Life Sciences Group Inc [SLS]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SLS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for SELLAS Life Sciences Group Inc go to 33.56%.
Insider trade positions for SELLAS Life Sciences Group Inc [SLS]
There are presently around $14.34%, or 14.38% of SLS stock, in the hands of institutional investors. The top three institutional holders of SLS stocks are: VANGUARD GROUP INC with ownership of 1.79 million shares, which is approximately 3.9862%. SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 1.64 million shares of the stock with an approximate value of $$1.95 million in SLS stocks shares; and SUSQUEHANNA INTERNATIONAL GROUP, LLP, currently with $$1.76 million in SLS stock with ownership which is approximately 3.3005%.
